col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: iScience
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―22 Effect of time and titer in convalescent plasma therapy for COVID-19 Paola de Candia, Francesco Prattichizzo, Silvia Garavelli, Rosalba La Grotta, Annunziata De Rosa, Agostina Pontarelli, et al. (+3)
2 [GO] 2021―Jul―21 A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples Tiantian Liu, Zhong Chen, Wanqiu Chen, Xin Chen, Maryam Hosseini, Zhaowei Yang, et al. (+6)
3 [GO] 2021―Jul―14 The Strand-biased Transcription of SARS-CoV-2 and Unbalanced Inhibition by Remdesivir Yan Zhao, Jing Sun, Yunfei Li, Zhengxuan Li, Yu Xie, Ruoqing Feng, et al. (+2)
4 [GO] 2021―Jul―10 Sensor Array and Gas Chromatographic Detection of the Blood Serum Volatolomic Signature of COVID-19 Yolande Ketchanji Mougang, Lorena Di Zazzo, Marilena Minieri, Rosamaria Capuano, Alexandro Catini, Jacopo Maria Legramente, et al. (+3)
5 [GO] 2021―Jul―09 Multi-Omics analysis of respiratory specimen characterizes baseline molecular determinants which associate with SARS-CoV-2 infection and outcome. Jaswinder Singh Maras, Shvetank Sharma, Adil Bhat, Sheetalnath Rooge, Reshu aggrawal, Ekta Gupta, Shiv K. Sarin
6 [GO] 2021―Jun―26 Graphene Nanoplatelet and Graphene Oxide Functionalization of Face Mask Materials Inhibits Infectivity of Trapped SARS-CoV-2 Flavio De Maio, Valentina Palmieri, Gabriele Babini, Alberto Augello, Ivana Palucci, Giordano Perini, et al. (+10)
7 [GO] 2021―Jun―24 Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance Patrick J. Lenehan, Eshwan Ramudu, A.J. Venkatakrishnan, Gabriela Berner, Reid McMurry, John C. O’Horo, et al. (+4)
8 [GO] 2021―Jun―24 ACE2 interaction with cytoplasmic PDZ protein enhances SARS-CoV-2 invasion Qiangmin Zhang, Julia Gefter, W. Bruce Sneddon, Tatyana Mamonova, Peter A. Friedman
9 [GO] 2021―Jun―19 Multi-dimensional and longitudinal systems profiling reveals predictive pattern of severe COVID-19 Marcel S. Woo, Friedrich Haag, Axel Nierhaus, Dominik Jarczak, Kevin Roedl, Christina Mayer, et al. (+14)
10 [GO] 2021―Jun―17 Dissecting the common and compartment-specific features of COVID-19 severity in the lung and periphery with single-cell resolution Kalon J. Overholt, Jonathan R. Krog, Ivan Zanoni, Bryan D. Bryson
11 [GO] 2021―Jun―10 Disease-dependent interaction policies to support health and economic outcomes during the COVID-19 epidemic Guanlin Li, Shashwat Shivam, Michael E. Hochberg, Yorai Wardi, Joshua S. Weitz
12 [GO] 2021―Jun―10 CD177, a specific marker of neutrophil activation, is associated with COVID-19 severity and death Yves Lévy, Aurélie Wiedemann, Boris P. Hejblum, Mélany Durand, Cécile Lefebvre, Mathieu Surénaud, et al. (+17)
13 [GO] 2021―Jun―09 A novel mouse AAV6 hACE2 transduction model of wild-type SARS-CoV-2 infection studied using synDNA immunogens Ebony N. Gary, Bryce M. Warner, Elizabeth M. Parzych, Bryan D. Griffin, Xizhou Zhu, Nikesh Tailor, et al. (+21)
14 [GO] 2021―Jun―01 Characterization of SARS-CoV-2 N protein reveals multiple functional consequences of the C-terminal domain Chao Wu, Abraham J. Qavi, Asmaa Hachim, Niloufar Kavian, Aidan R. Cole, Austin B. Moyle, et al. (+10)
15 [GO] 2021―May―24 SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals Peter V. Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, Naema Hassan Abdulla Al Molawi, Reham Awni El Kahlout, Imtiaz Gilliani, et al. (+18)
16 [GO] 2021―May―18 Phenome-wide and eQTL Associations of COVID-19 Genetic Risk Loci Chang Moon, Brian M. Schilder, Towfique Raj, Kuan-lin Huang
17 [GO] 2021―May―07 Energetic and structural features of SARS-CoV-2 N-protein co-assemblies with nucleic acids Huaying Zhao, Di Wu, Ai Nguyen, Yan Li, Regina C. Adão, Eugene Valkov, et al. (+3)
18 [GO] 2021―May―01 Comparative Analysis of Antibodies to SARS-CoV-2 between Asymptomatic and Convalescent Patients Connor J. Dwyer, Colleen A. Cloud, Cindy Wang, Philip Heidt, Paramita Chakraborty, Tara F. Duke, et al. (+21)
19 [GO] 2021―Apr―26 Experimental and natural evidence of SARS-CoV-2 infection-induced activation of type I interferon responses Arinjay Banerjee, Nader El-Sayes, Patrick Budylowski, Rajesh Abraham Jacob, Daniel Richard, Hassaan Maan, et al. (+22)
20 [GO] 2021―Apr―26 Therapeutic antibodies, targeting the SARS-CoV-2 spike N-terminal domain, protect lethally infected K18-hACE2 mice Tal Noy-Porat, Adva Mechaly, Yinon Levy, Efi Makdasi, Ron Alcalay, David Gur, et al. (+18)
21 [GO] 2021―Apr―21 Cell type resolved quantitative proteomics map of interferon response against SARS-CoV-2 Elisa Saccon, Xi Chen, Flora Mikaeloff, Jimmy Esneider Rodriguez, Laszlo Szekely, Beatriz Sá Vinhas, et al. (+7)
22 [GO] 2021―Apr―19 Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells Emi Sano, Sayaka Deguchi, Ayaka Sakamoto, Natsumi Mimura, Ai Hirabayashi, Yukiko Muramoto, et al. (+3)
23 [GO] 2021―Mar―19 Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19 Immacolata Andolfo, Roberta Russo, Vito Alessandro Lasorsa, Sueva Cantalupo, Barbara Eleni Rosato, Ferdinando Bonfiglio, et al. (+15)
24 [GO] 2021―Mar―19 Learning from HIV-1 to predict the immunogenicity of T cell epitopes in SARS-COV-2 Ang Gao, Zhilin Chen, Assaf Amitai, Julia Doelger, Vamsee Mallajosyula, Emily Sundquist, et al. (+6)
25 [GO] 2021―Mar―14 The Silent Pandemic: Emergent Antibiotic Resistances Following the Global Response to SARS-CoV-2 Andrew R. Mahoney, Mohammad Moein Safaee, William M. Wuest, Ariel L. Furst
26 [GO] 2021―Mar―10 SARS-CoV-2, SARS-CoV-1, and HIV-1 derived ssRNA sequences activate the NLRP3 inflammasome in human macrophages through a non-classical pathway Grant R. Campbell, Rachel K. To, Jonathan Hanna, Stephen A. Spector
27 [GO] 2021―Mar―10 Title: ORF8 contributes to cytokine storm during SARS-CoV-2 infection by activating IL-17 pathway Xiaoyuan Lin, Beibei Fu, Songna Yin, Zhifeng Li, Huawen Liu, Haiwei Zhang, et al. (+12)
28 [GO] 2021―Mar―07 A meta-analysis on the role of pre-existing chronic disease in the cardiac complications of SARS-CoV-2 infection Jane E. Sinclair, Yanshan Zhu, Gang Xu, Wei Ma, Haiyan Shi, Kun-Long Ma, et al. (+9)
29 [GO] 2021―Mar―01 Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19 Qu Deng, Reyaz ur Rasool, Ronnie M. Russell, Ramakrishnan Natesan, Irfan A. Asangani
30 [GO] 2021―Feb―23 Heuristic Thinking and Altruism towards Machines in People Impacted by Covid-19 Celso M. de Melo, Jonathan Gratch, Frank Krueger
31 [GO] 2021―Feb―16 Pre-existing conditions in Hispanics/Latinxs that are COVID-19 risk factors Timothy S. Chang, Yi Ding, Malika K. Freund, Ruth Johnson, Tommer Schwarz, Julie M. Yabu, et al. (+6)
32 [GO] 2021―Feb―16 Structural insight reveals SARS-CoV-2 ORF7a as an immunomodulating factor for human CD14+ monocytes Ziliang Zhou, Chunliu Huang, Zhechong Zhou, Zhaoxia Huang, Lili Su, Sisi Kang, et al. (+7)
33 [GO] 2021―Feb―10 Quantitative Assays Reveal Cell Fusion at Minimal Levels of SARS-CoV-2 Spike Protein and Fusion-from-Without Samuel A. Theuerkauf, Alexander Michels, Vanessa Riechert, Thorsten J. Maier, Egbert Flory, Klaus Cichutek, Christian J. Buchholz
34 [GO] 2021―Feb―07 Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy Wyler Emanuel, Mösbauer Kirstin, Franke Vedran, Diag Asija, Gottula Lina Theresa, Arsiè Roberto, et al. (+22)
35 [GO] 2021―Feb―06 Proteomic Investigation Reveals Dominant Alterations of Neutrophil Degranulation and mRNA Translation Pathways in COVID-19 Patients Renuka Bankar, Kruthi Suvarna, Saicharan Ghantasala, Arghya Banerjee, Deeptarup Biswas, Manisha Choudhury, et al. (+13)
36 [GO] 2021―Jan―28 Mutational signatures and heterogeneous host response revealed via large-scale characterization of SARS-CoV-2 genomic diversity Alex Graudenzi, Davide Maspero, Fabrizio Angaroni, Rocco Piazza, Daniele Ramazzotti
37 [GO] 2021―Jan―22 The presentation of SARS-CoV-2 peptides by the common HLA-A*02:01 molecule Christopher Szeto, Demetra S.M. Chatzileontiadou, Andrea T. Nguyen, Hannah Sloane, Christian A. Lobos, Dhilshan Jayasinghe, et al. (+5)
38 [GO] 2021―Jan―20 The outbreak of COVID-19 altered the relationship between current negative memory biases and future depressive degree in nonclinical depression Pengyu Zhang, Yi Piao, Ying Chen, Jiecheng Ren, Longhua Zhang, Bensheng Qiu, et al. (+2)
39 [GO] 2021―Jan―12 A high-throughput liquid bead-array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity Monique Bennett, Sandra Yoder, Eric Brady, Jill M. Pulley, Jillian P. Rhoads, Thomas G. Stewart, et al. (+4)
40 [GO] 2021―Jan―10 A multi-pronged approach targeting SARS-CoV-2 proteins using ultra-large virtual screening Christoph Gorgulla, Krishna M. Padmanabha Das, Kendra E. Leigh, Marco Cespugli, Patrick D. Fischer, Zi-Fu Wang, et al. (+31)
41 [GO] 2020―Dec―27 High-Throughput Rational Design of the Remdesivir Binding Site in the RdRp of SARS-CoV-2: Implications for Potential Resistance Aditya K. Padhi, Rohit Shukla, Prakash Saudagar, Timir Tripathi
42 [GO] 2020―Dec―16 Transcriptomic Similarities and Differences in Host Response between SARS-CoV-2 and Other Viral Infections Simone A. Thair, Yudong D. He, Yehudit Hasin-Brumshtein, Suraj Sakaram, Rushika Pandya, Jiaying Toh, et al. (+13)
43 [GO] 2020―Dec―07 Transcriptional response modules characterise IL-1β and IL-6 activity in COVID-19 Lucy CK. Bell, Cem Meydan, Jacob Kim, Jonathan Foox, Daniel Butler, Christopher E. Mason, et al. (+3)
44 [GO] 2020―Dec―07 Structural characterization of Nonstructural protein 1 from SARS-CoV-2 Cameron Semper, Nobuhiko Watanabe, Alexei Savchenko
45 [GO] 2020―Nov―28 Remdesivir is effective in combating COVID-19 because it is a better substrate than ATP for the viral RNA-dependent RNA polymerase Tyler L. Dangerfield, Nathan Z. Huang, Kenneth A. Johnson
46 [GO] 2020―Nov―25 SARS-CoV-2 receptors and entry genes are expressed in the human olfactory neuroepithelium and brain Leon Fodoulian, Joel Tuberosa, Daniel Rossier, Madlaina Boillat, Chenda Kan, Véronique Pauli, et al. (+5)
47 [GO] 2020―Nov―13 Innate and adaptive immunity of murine neural stem cell-derived piRNA exosomes/microvesicles against pseudotyped SARS-CoV-2 and HIV-based lentivirus Bin Yu, Shoeb Ikhlas, Chunsheng Ruan, Xingxing Zhong, Dongsheng Cai
48 [GO] 2020―Oct―28 The SARS-CoV-2 targets by the pscRNA profiling of ACE2, TMPRSS2 and Furin proteases Lulin Zhou, Zubiao Niu, Xiaoyi Jiang, Zhengrong Zhang, You Zheng, Zhongyi Wang, et al. (+5)
49 [GO] 2020―Oct―26 Robust and specific secretory IgA against SARS-CoV-2 detected in human milk Alisa Fox, Jessica Marino, Fatima Amanat, Florian Krammer, Jennifer Hahn-Holbrook, Susan Zolla-Pazner, Rebecca L. Powell
50 [GO] 2020―Oct―05 Furin, a potential therapeutic target for COVID-19 Canrong Wu, Mengzhu Zheng, Yueying Yang, Xiaoxia Gu, Kaiyin Yang, Mingxue Li, et al. (+10)
51 [GO] 2020―Oct―05 Impact of COVID-19 measures on short-term electricity consumption in the most affected EU countries and USA states Javier López Prol, Sungmin O
52 [GO] 2020―Oct―05 SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil-Redondo, Tammo Diercks, Eunate Arana, Aitor García de Vicuña, et al. (+13)
53 [GO] 2020―Sep―29 Mitochondria - in the crossfire of SARS-CoV-2 and immunity Johannes Burtscher, Giuseppe Cappellano, Akiko Omori, Takumi Koshiba, Grégoire P. Millet
54 [GO] 2020―Sep―25 PPARγ cistrome repression during activation of lung monocyte-macrophages in severe COVID-19 Christophe Desterke, Ali G. Turhan, Annelise Bennaceur-Griscelli, Frank Griscelli
55 [GO] 2020―Sep―23 SARS-CoV-2 infection boosts MX1 antiviral effector in COVID-19 patients Juan Bizzotto, Pablo Sanchis, Mercedes Abbate, Sofía Lage-Vickers, Rosario Lavignolle, Ayelén Toro, et al. (+6)
56 [GO] 2020―Sep―03 Integrative Network Biology Framework Elucidates Molecular Mechanisms of SARS-CoV-2 Pathogenesis Nilesh Kumar, Bharat Mishra, Adeel Mehmood, Mohammad Athar
57 [GO] 2020―Jul―31 ACE2, Metformin, and COVID-19 Atul Malhotra, Mark Hepokoski, Karen C. McCowen, John Y-J Shyy
58 [GO] 2020―Jul―28 The MERS-CoV Receptor DPP4 as a Candidate Binding Target of the SARS-CoV-2 Spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
59 [GO] 2020―Jul―25 Molecular and immunological diagnostic tests of COVID-19 - current status and challenges Tugba Kilic, Ralph Weissleder, Hakho Lee
60 [GO] 2020―Jul―18 ACE2 co-evolutionary pattern suggests targets for pharmaceutical intervention in the COVID-19 pandemic Maya Braun, Elad Sharon, Irene Unterman, Maya Miller, Anna Mellul Shtern, Shmuel Benenson, et al. (+2)
61 [GO] 2020―Jun―20 Current status of COVID-19 therapies and drug repositioning applications Ozlem Altay, Elyas Mohammadi, Simon Lam, Hasan Turkez, Jan Boren, Jens Nielsen, et al. (+2)
62 [GO] 2020―Jun―20 CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 Roman Martin, Hannah F. Löchel, Marius Welzel, Georges Hattab, Anne-Christin Hauschild, Dominik Heider
63 [GO] 2020―Jun―09 Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9 Dene R. Littler, Benjamin S. Gully, Rhys N. Colson, Jamie Rossjohn
64 [GO] 2020―May―30 Mitigating coronavirus-induced acute respiratory distress syndrome by radiotherapy Jian Jian Li
65 [GO] 2020―May―28 Proteolytic cleavage of the SARS-CoV-2 spike protein and the role of the novel S1/S2 site Javier A. Jaimes, Jean K. Millet, Gary R. Whittaker
66 [GO] 2020―May―13 The MERS-CoV receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike Yu Li, Ziding Zhang, Li Yang, Xianyi Lian, Yan Xie, Shen Li, et al. (+3)
67 [GO] 2020―May―12 In the Race to Help with Covid-19, Time Is Precious: Editorial Guidelines for Coronavirus Papers Simona Fiorani, Stefano Tonzani

[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.014 sec